Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3, 2002, Pages 389-396

  Wei, S ^a   Kito, K ^a   Miyoshi, A ^a   Matsumoto, S ^a   Kauzi, A ^a   Aramoto, T ^a   Abel, Y ^a   Ueda, Norifumi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

7,12 dimethylbenz(a)anthracene; Fluorescence labeled PCR SSCP; H ras gene; K ras gene; Leukemia; N ras gene; p53 gene; Point mutation

Indexed keywords

ADENINE; AMINO ACID; ARGININE; CYTOSINE; DIMETHYLBENZ[A]ANTHRACENE; GLYCINE; GUANINE; HISTAMINE; LEUCINE; PROTEIN P53; RAS PROTEIN; THYMIDINE; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CODON; CONTROLLED STUDY; EXON; FEMALE; FLUORESCENCE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; LEUKEMIA; MALE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; LEUKEMIA, EXPERIMENTAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RATS; RATS, LONG-EVANS;

EID: 0036736924     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rodenhuis S.: Ras and human tumors. Semin. Cancer Bil. 3:241-247,1992.
2. Farr C.J., Saiki R.K., Erlich H.A., McCormick F., Marshall C.J.: Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl. Acad. Sci. USA 85:1629-1633, 1988.
3. Lubbert M., Miro J.J., Kitchingman G. etc.: Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 7:263-268, 1992.
4. Huggins C.B. and Sugiyama T.: Induction of leukemia in rat by pulse doses of 7,1 2-dimethylbenzaanthracene. Proc. Natl. Acad. Sci. USA 55:74-81, 1966.
5. Sugiyama T., Uenaka H., Ueda N., Fukuhara A.S., Maeda S.: Reproducible chromosome changes of polycyclic hydrocarbon-induced rat leukemia: Incidence and chromosome banding pattern. J. Natl. Cancer Inst. 60:153-160, 1978.
6. Osaka M., Matsuo S., Koh T. et al.: N-ras mutation in 7,12 dimethylbenz(a)anthracene(DMBA)-induced erythroleukemia in Long-Evans rats. Cancer Lett 91:25-31, 1995.
7. Takeda S., Ichi S., Nakamura Y.: Detection of K-ras mutation in sputum by mutant mutant-allele-specific amplification(MASA). Hum. Mutat. 2:112-117, 1993.
8. Osaka M., Kazama T., Matsuo S., Koh T., Maeda S., Sugiyama T.: Specific N-ras mutation appears within 48 hours in bone marrow after 7,12 dimethylbenz(a)anthracene(DMBA) treatment in Huggins-Sugiyama rat leukemogenesis. Mol. Carcinogen. 16:126-31, 1996.
9. Osaka M., Matsuo S., Koh T., Sugiyama T.: Loss of heterozygosity at the N-ras locus in 7,12 dimethylbenz(a)anthracene-induced rat leukemia. Molecular Carcinogenesis 18:206-216, 1997.
10. Osaka M., Koami K., Sugiyama T.: WT1 contributes to the leukemogenesis: expression pattern in 7,12-dimethylben(a) anthracene (DMBA)-induced leukemia. 72:696-699, 1997.
11. kirsch D.G., Kastan M.B.: Tumor-suppressor p53: Implications for tumor development and prognosis. J. Clin. Oncol. 16:3158-3168, 1998.
12. Finlay C.A., Hinds P.W., Levine A.J.: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093, 1989.
13. Hollstein M., Sidransky D., Vogelstein Harris C.C.: p53 mutations in human cancer. Science 253:49-53, 1991.
14. Jonveaux P.H., Fenaux P., Quiquandon I. et al.: Mutation in the p53 gene in myelodysplastic syndromes. Oncogene 6:2243-2247, 1991.
15. Fenaus P., Preudhomme C., Quiquandon I. et al.: Mutations of p53 gene in acute myeloid leukemia. Br. J. Haematol. 80:178-183, 1992.
16. Mashal R., Shtalrid M., Talpaz M. et al.: Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 75:180-189, 1990.
17. Sugimoto K., Toyoshima H., Sakai R. et al.: Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79:2378-2383, 1992.
18. Greenblatt W.P., Bennett M., Hollstein H.: Mutation of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878, 1994.
19. Huggins C.B., Ueda N., Russo A.: Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proc. Natl. Acad. Sci. USA 75:4524-4527, 1978.
20. Murakami Y., Hayashi K., Sekiya T.: Detection of aberrations of P53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Research 51:3356-3361, 1991.
21. Tanis E., Hulla and Richard P., Schneider: Structure of the rat p53 tumor suppressor gene. Nucleic Acids Research 21:713-717, 1993.
22. Soussi T., de Fromentel C.C., Breugnot C., May E.: Nucleotide sequence of a CDNA encoding the rat p53 nuclear protein. Nucleic Acids Research 16:11384, 1988.
23. George D.L., Scott A.F., Trusko S., Glick B., Ford E., Dorney D.J.: Structure and expression of amplified cKi-ras sequences in Y1 mouse adrenal tumor cells. EMBO J 4:1199-1203, 1985.
24. Guerrero L., Villasante A., Corces V., Pellicer A.: Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc. Natl. Acad. Sci. USA 82:7810-7814, 1985.
25. Wang Y., You M., Roynolds S.H., Stoner G.D., Anderson M.W.: Mutational activation of the cellular Harvey-ras oncogene in rat esophageal papillomas induced by ethylbenzylnitrosamine. Cancer Research 50:1591-1595, 1990.
26. Makino R., Yazuyu H., Kishimoto Y., Sekiya T., Hayashi K.: F-SSCP: Fluorescene-based polymerase chain reaction single strand conformation polymorphism (PCR-SSCP) analysis. PCR Methods App. 2:10-13, 1994.
27. van Kranen H.J., Van Steeg H., Schoren L. et al.: The rat N-ras gene; interference of pseudogenes with the detection of activating point mutations. Carcinogenesis 15:307-311, 1994.
28. Savov A., Anfelicheva D., Jordanova A., Eigel A., Kalaydijieva L.: High percentage acrylamide gels improve resolution in SSCP analysis. Nucleic Acids Res 20:6741-6742, 1992.
29. Miller J.A. and Miller E.C.: The metabolic activation of chemical carcinogens to reactive electrophiles. In: Yuhas JM, Tennant RW, Regan JD(eds), Biology of radiation carcinogenesis. Raven Press, New York, 1976, pp. 147-164.
30. Bizub D., Wood A.W., Skalka A.M.: Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. USA 83:6048-6052, 1986.
31. Kito K., Kihana T., Sugita A. et al.: Incidnce of p53 ns Ha-ras gene Mutations in chemically induced rat mammary carcinomas. Mol. Carcinog. 17:78-83, 1996.
32. Maher J., Baker D.A., Manning M., Dibb N.J., Roberts I.A.G.: Evidence for cell-specific differences in transformation by NH- and K-ras. Oncogene 11:1639-1647, 1995.
33. Manjianatha M.G., Chen J.B., Shaddock J.G., J.R., Harris A.J., Shelton S.D., Casciano D.A.: Molecular analysis of LacI mutations in Rat2 cells exposed to 7,12-dimethybenz(a)anthracene: evidence for DNA sequence and DNA strand biases for mutation. Mutation Res. 372:53-56, 1996.
34. Makino H., Ushijima T., Kakiuchi H. et al.: Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo]4,5-b]pyridine. Jpn. J. Cancer Res. 85:510-514, 1994.
35. Ushijima T., Kakiuchi H., Makino H. et al.: Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine. Mol. Carcinog. 10:38-44, 1994.
36. Makino H., Ishizaka Y., Tsujimoto A. et al.: Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. USA 89:4850-4854, 1992.